Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.
Test Segments: Market Sizing and Forecasts
There are several segments where testing at the molecular level has thrived, including the following:
• HPV Testing
• CT/NG Testing
• Molecular Hepatitis Testing
• HIV Testing
• Hospital Acquired Infections and Sepsis Testing
• Respiratory Diseases Testing
• Mycobacteria/Tuberculosis Testing
The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition.
For each of these segments, the report provides a breakout for the following regions:
• North America
• Asia Pacific
Companies covered in this report include: